Calcium deficiency in the early stages after weaning is associated with the enhancement of a low level of adrenaline-stimulated lipolysis and reduction of adiponectin release in isolated rat mesenteric adipocytes

Metabolism: Clinical and Experimental

Volumn 59, Issue 7, 2010, Pages 951-958

  Shinoki, Aki ^a   Hara, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADRENALIN; CALCIUM; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PARATHYROID HORMONE; SUCROSE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM DEFICIENCY; CALCIUM INTAKE; CARBOHYDRATE DIET; CELL ISOLATION; CELL SIZE; CONTROLLED STUDY; CYTOKINE RELEASE; FOOD INTAKE; HORMONE BLOOD LEVEL; LIPOLYSIS; MALE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RAT; WEANING;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ANIMALS; BODY WEIGHT; CALCIUM; CELL SIZE; DIET; EATING; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; LIPIDS; LIPOLYSIS; MALE; MESENTERY; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE; WEANING;

EID: 77952791257     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.10.016     Document Type: Article

References (42)

1. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. Funahashi T., Nakamura T., Shimomura I., et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38 (1999) 202-206
3. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 580 (2006) 2917-2921
4. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
5. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
6. Schrager S. Dietary calcium intake and obesity. J Am Board Fam Pract 18 (2005) 205-210
7. Pikilidou M.I., Lasaridis A.N., Sarafidis P.A., et al. Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with type 2 diabetes. Diabet Med 26 (2009) 211-219
8. Liu S., Song Y., Ford E.S., Manson J.E., Buring J.E., and Ridker P.M. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28 (2005) 2926-2932
9. Pittas A.G., Dawson-Hughes B., Li T., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29 (2006) 650-656
10. Pittas A.G., Lau J., Hu F.B., and Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92 (2007) 2017-2029
11. Pereira M.A., Jacobs Jr. D.R., Van Horn L., Slattery M.L., Kartashov A.I., and Ludwig D.S. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 287 (2002) 2081-2089
12. Griffith L., Guyatt G.H., Cook R.J., Bucher H.C., and Cook D.J. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 12 (1999) 84-92
13. McCarron D., and Reusser M.E. Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr 18 (1999) 398S-405S
14. Byyny R.L., LoVerde M., Lloyd S., Mitchell W., and Draznin B. Cytosolic calcium and insulin resistance in elderly patients with essential hypertension. Am J Hypertens 5 (1992) 459-464
15. Draznin B., Sussman K.E., Eckel R.H., Kao M., Yost T., and Sherman N.A. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 82 (1988) 1848-1852
16. Chang E., Donkin S.S., and Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol 307 (2009) 77-82
17. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993) 1939-1951
18. Rodbell M. Merabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239 (1964) 375-380
19. Bays H., Mandarino L., and DeFronzo R.A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89 (2004) 463-478
20. Nguyen M.T., Satoh H., Favelyukis S., et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280 (2005) 35361-35371
21. Zemel M.B., Shi H., Greer B., Dirienzo D., and Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 14 (2000) 1132-1138
22. Sun X., and Zemel M.B. Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 15 (2007) 340-348
23. Sun X., and Zemel M.B. 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor. Int J Obes (Lond) 32 (2008) 1305-1311
24. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 (2004) 820-825
25. Ford E.S., Ajani U.A., McGuire L.C., and Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28 (2005) 1228-1230
26. Sun G., Vasdev S., Martin G.R., Gadag V., and Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 54 (2005) 3336-3339
27. Reis J.P., von Mühlen D., Kritz-Silverstein D., Wingard D.L., and Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30 (2007) 1549-1555
28. Reis J.P., von Mühlen D., and Miller III E.R. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159 (2008) 41-48
29. Altomonte J., Harbaran S., Richter A., and Dong H. Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism 52 (2003) 958-963
30. Chandran M., Phillips S.A., Ciaraldi T., and Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 26 (2003) 2442-2450
31. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
32. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
33. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
34. Ruan H., and Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 14 (2003) 447-455
35. Edens N.K., Fried S.K., Kral J.G., Hirsch J., and Leibel R.L. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol 265 (1993) E374-E379
36. Farnier C., Krief S., Blache M., et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord 27 (2003) 1178-1186
37. Franck N., Stenkula K.G., Ost A., Lindström T., Strålfors P., and Nystrom F.H. Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia 50 (2007) 1716-1722
38. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., and Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43 (2000) 1498-1506
39. Graham S.J., Black M.J., Soboloff J., Gill D.L., Dziadek M.A., and Johnstone L.S. Stim1, an endoplasmic reticulum Ca2+ sensor, negatively regulates 3T3-L1 pre-adipocyte differentiation. Differentiation 77 (2009) 239-247
40. Chiu K.C., Chuang L.M., Lee N.P., et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 49 (2000) 1501-1505
41. DeFronzo R.A., Smith D., and Alvestrand A. Insulin action in uremia. Kidney Int Suppl 16 (1983) S102-S114
42. Kumar S., Olukoga A.O., Gordon C., et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 40 (1994) 47-53